跳至主要内容
临床试验/JPRN-jRCTs051190021
JPRN-jRCTs051190021已完成1 期

Endovascular cannulation with a microneedle for retinal vein occlusion or retinal artery occulusion - Endovascular cannulation with a microneedle for RVO or RAO

Kojima Kentaro0 个研究点目标入组 5 人开始时间: 2019年5月21日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
5

研究概览

简要总结

Five patients were enrolled in the study. In this study, endovascular treatment with tissue-type plasminogen activator for retinal vascular occlusion can be performed without major complications, but there are still issues such as the difficulty of the procedure. Because this study was conducted on an unexpectedly small number of patients, detailed statistical analysis could not be performed, and conclusions regarding efficacy and safety cannot be drawn.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • 1 Over 20 years old at the time of this research registration
  • 2 The patients stay in hospital for one week after vitrectomy
  • 3 The patients agree with the document to be explained in obtaining informed consent
  • 4 There is no history of cerebrovascular disorders such as cerebral infarction and drugs used in this study don't induce a deteriorating factor.

排除标准

  • At the time of registration, the cases in which drugs in this study are expected to influence past diseases.

研究者

发起方
Kojima Kentaro

相似试验